Lassman, Scott M <br/><br/>
Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.  [electronic resource] 

 -  BMJ open  Sep 2017 
 - e015110 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2044-6055 
<br/><br/><label>Standard No.: </label>10.1136/bmjopen-2016-015110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Access to Information<br/>Clinical Trials as Topic<br/>Cross-Sectional Studies--statistics & numerical data<br/>Disclosure--legislation & jurisprudence<br/>Drug Approval<br/>Drug Industry<br/>Humans<br/>Registries--statistics & numerical data<br/>United States<br/>United States Food and Drug Administration